Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 7/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | THPO | P40225 | 1/20 | 0.39 |
| ▸ | RECQL | P46063 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ACE | P12821 | 2/20 | 0.35 |
| ▸ | ENPEP | Q07075 | 2/20 | 0.34 |
| ▸ | ANPEP | P15144 | 1/20 | 0.34 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.34 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.34 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.31 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.31 |
| ▸ | MME | P08473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5729609 | 1.00 | FOLH1 (0.39) | FOLH1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL1775718 | 0.84 | — | — | |
| SCHEMBL57052 | 0.84 | — | — | |
| SCHEMBL1830619 | 0.84 | — | — | |
| SCHEMBL3263169 | 0.82 | — | — | |
| SCHEMBL9486335 | 0.80 | FOLH1 (0.38) | FOLH1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL31510814 | 0.80 | ACE (0.42) | FOLH1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL9633039 | 0.80 | FOLH1 (0.38) | FOLH1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL4543595 | 0.80 | KDM4E (0.47) | FOLH1KDM4EMAPTTHRBALOX15 | |
| SCHEMBL5372700 | 0.80 | KDM4E (0.47) | FOLH1KDM4EMAPTTHRBALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 931 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026044058-A1 | SLIPPERY ORGANOGELS AND METHODS FOR MAKING AND USING THE SAME | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2026-02-26 | — | — | WO | claimed |
| US-20250135170-A1 | COMPOSITIONS AND ARTICLES FOR DELIVERING NITRIC OXIDE AND METHODS FOR MAKING AND USING THE SAME | UNIV GEORGIA (US) | 2025-05-01 | — | — | US | claimed |
| US-20240374562-A1 | METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS | EPICENTRX, INC. (US) | 2024-11-14 | — | — | US | claimed |
| WO-2024189434-A1 | USE OF NADOLOL TO TREAT PULMONARY SYMPTOMS ASSOCIATED WITH INFECTIONS WITH SARS-CoV-2 | CHRONIC AIRWAY THERAPEUTICS LIMITED (AU) | 2024-09-19 | — | — | WO | claimed |
| EP-4304717-A1 | USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY | Chronic Airway Therapeutics Limited (AU) | 2024-01-17 | — | — | EP | claimed |
| WO-2022192252-A1 | USE OF NADOLOL TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE BY BLOCKAGE OF THE ARRESTIN-2 PATHWAY | CHRONIC AIRWAY THERAPEUTICS LIMITED (AU) | 2022-09-15 | — | — | WO | claimed |
| US-20190336602-A1 | STERILISATION OF S-NITROSOTHIOLS | Salupont Consulting Ltd. (GB) | 2019-11-07 | — | — | US | claimed |
| US-20180055932-A1 | STERILISATION OF S-NITROSOTHIOLS | Salupont Consulting Ltd. (GB) | 2018-03-01 | — | — | US | claimed |
| EP-3274001-A1 | STERILISATION OF S-NITROSOTHIOLS | Salupont Consulting Ltd. (GB) | 2018-01-31 | — | — | EP | claimed |
| US-9702842-B2 | Amperometric sensors and devices for measuring concentration of S-nitrosothiols based on photo-induced decomposition of S-nitrosothiols | I-SENS, INC. (KR) | 2017-07-11 | — | — | US | claimed |
| EP-0850053-A1 | ERYTHROCYTES LOADED WITH S-NITROSOTHIOL AND USES THEREFOR | DUKE UNIVERSITY MEDICAL CENTER (US) | 1998-07-01 | — | — | EP | claimed |
| WO-1998008566-A1 | MANIPULATIONS OF NITROSATIVE AND OXIDATIVES STRESS IN THE TREATMENT OF DISEASE | DUKE UNIVERSITY (US) | 1998-03-05 | — | — | WO | claimed |
| US-5648393-A | Treatment of male impotence with s-nitrosylated compounds | BRIGHAM & WOMEN'S HOSPITAL (US) | 1997-07-15 | — | — | US | claimed |
| WO-1997018000-A1 | S-NITROSO-HEMOGLOBIN AND THERAPEUTIC USES THEREOF | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1997-05-22 | — | — | WO | claimed |
| US-5626738-A | Methods for the separation and detection of nitrosothiols | AMERICAN HEALTH FOUNDATION (US) | 1997-05-06 | — | — | US | claimed |
| WO-1997009972-A1 | ERYTHROCYTES LOADED WITH S-NITROSOTHIOL AND USES THEREFOR | DUKE UNIVERSITY MEDICAL CENTER (US) | 1997-03-20 | — | — | WO | claimed |
| US-5385937-A | Preventing peroxide generation from mercaptan groups and endothelial injury | BRIGHAM & WOMEN'S HOSPITAL (US) | 1995-01-31 | — | — | US | claimed |
| US-5380758-A | Respiratory, gastrointestinal | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1995-01-10 | — | — | US | claimed |
| WO-1994016740-A1 | THE USE OF NITRIC OXIDE-DELIVERING COMPOUNDS FOR THE TREATMENT OR PREVENTION OF ALCOHOLIC LIVER INJURY | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1994-08-04 | — | — | WO | claimed |
| WO-1993012068-A1 | S-NITROSOTHIOLS AS SMOOTH MUSCLE RELAXANTS AND THERAPEUTIC USES THEREOF | BRIGHAM AND WOMEN'S HOSPITAL (US) | 1993-06-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190336602-A1 | STERILISATION OF S-NITROSOTHIOLS | SULT1A1, SRM, SULT2A1 | FOLH1 418/4885KDM4E 3768/4885MAPT 2914/4885 |
| US-20240374562-A1 | METHODS AND COMPOSITIONS COMPRISING A NITRITE-REDUCTASE PROMOTER FOR TREATMENT OF MEDICAL DISORDERS AND PRESERVATION OF BLOOD PRODUCTS | HBB, HBG2, HBZ | FOLH1 1541/4885KDM4E 645/4885MAPT 4665/4885 |
| US-20180055932-A1 | STERILISATION OF S-NITROSOTHIOLS | SULT1A1, SRM, SULT2A1 | FOLH1 418/4885KDM4E 3768/4885MAPT 2914/4885 |
| US-20250135170-A1 | COMPOSITIONS AND ARTICLES FOR DELIVERING NITRIC OXIDE AND METHODS FOR MAKING AND USING THE SAME | NOS2, NOS1, NOS3 | FOLH1 1886/4885KDM4E 2861/4885MAPT 3861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.